Lung Cancer
Lung Cancer market is segmented by players, region (country), by Type and by Application. Players ... Read More
Global Lower GI Series Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lower GI Series Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Double-Contrast
1.2.3 Single-Contrast
1.3 Market by Application
1.3.1 Global Lower GI Series Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lower GI Series Market Perspective (2017-2028)
2.2 Lower GI Series Growth Trends by Region
2.2.1 Lower GI Series Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Lower GI Series Historic Market Size by Region (2017-2022)
2.2.3 Lower GI Series Forecasted Market Size by Region (2023-2028)
2.3 Lower GI Series Market Dynamics
2.3.1 Lower GI Series Industry Trends
2.3.2 Lower GI Series Market Drivers
2.3.3 Lower GI Series Market Challenges
2.3.4 Lower GI Series Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lower GI Series Players by Revenue
3.1.1 Global Top Lower GI Series Players by Revenue (2017-2022)
3.1.2 Global Lower GI Series Revenue Market Share by Players (2017-2022)
3.2 Global Lower GI Series Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lower GI Series Revenue
3.4 Global Lower GI Series Market Concentration Ratio
3.4.1 Global Lower GI Series Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lower GI Series Revenue in 2021
3.5 Lower GI Series Key Players Head office and Area Served
3.6 Key Players Lower GI Series Product Solution and Service
3.7 Date of Enter into Lower GI Series Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lower GI Series Breakdown Data by Type
4.1 Global Lower GI Series Historic Market Size by Type (2017-2022)
4.2 Global Lower GI Series Forecasted Market Size by Type (2023-2028)
5 Lower GI Series Breakdown Data by Application
5.1 Global Lower GI Series Historic Market Size by Application (2017-2022)
5.2 Global Lower GI Series Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lower GI Series Market Size (2017-2028)
6.2 North America Lower GI Series Market Size by Country (2017-2022)
6.3 North America Lower GI Series Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Lower GI Series Market Size (2017-2028)
7.2 Europe Lower GI Series Market Size by Country (2017-2022)
7.3 Europe Lower GI Series Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lower GI Series Market Size (2017-2028)
8.2 Asia-Pacific Lower GI Series Market Size by Country (2017-2022)
8.3 Asia-Pacific Lower GI Series Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Lower GI Series Market Size (2017-2028)
9.2 Latin America Lower GI Series Market Size by Country (2017-2022)
9.3 Latin America Lower GI Series Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lower GI Series Market Size (2017-2028)
10.2 Middle East & Africa Lower GI Series Market Size by Country (2017-2022)
10.3 Middle East & Africa Lower GI Series Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eisai
11.1.1 Eisai Company Detail
11.1.2 Eisai Business Overview
11.1.3 Eisai Lower GI Series Introduction
11.1.4 Eisai Revenue in Lower GI Series Business (2017-2022)
11.1.5 Eisai Recent Development
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Company Detail
11.2.2 Cadila Pharmaceuticals Business Overview
11.2.3 Cadila Pharmaceuticals Lower GI Series Introduction
11.2.4 Cadila Pharmaceuticals Revenue in Lower GI Series Business (2017-2022)
11.2.5 Cadila Pharmaceuticals Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Detail
11.3.2 Purdue Pharma Business Overview
11.3.3 Purdue Pharma Lower GI Series Introduction
11.3.4 Purdue Pharma Revenue in Lower GI Series Business (2017-2022)
11.3.5 Purdue Pharma Recent Development
11.4 Peacehealth
11.4.1 Peacehealth Company Detail
11.4.2 Peacehealth Business Overview
11.4.3 Peacehealth Lower GI Series Introduction
11.4.4 Peacehealth Revenue in Lower GI Series Business (2017-2022)
11.4.5 Peacehealth Recent Development
11.5 Novadaq
11.5.1 Novadaq Company Detail
11.5.2 Novadaq Business Overview
11.5.3 Novadaq Lower GI Series Introduction
11.5.4 Novadaq Revenue in Lower GI Series Business (2017-2022)
11.5.5 Novadaq Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Detail
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Lower GI Series Introduction
11.6.4 Astrazeneca Revenue in Lower GI Series Business (2017-2022)
11.6.5 Astrazeneca Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Detail
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Lower GI Series Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2017-2022)
11.7.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Lower GI Series Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Double-Contrast
Table 3. Key Players of Single-Contrast
Table 4. Global Lower GI Series Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Lower GI Series Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Lower GI Series Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Lower GI Series Market Share by Region (2017-2022)
Table 8. Global Lower GI Series Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Lower GI Series Market Share by Region (2023-2028)
Table 10. Lower GI Series Market Trends
Table 11. Lower GI Series Market Drivers
Table 12. Lower GI Series Market Challenges
Table 13. Lower GI Series Market Restraints
Table 14. Global Lower GI Series Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Lower GI Series Market Share by Players (2017-2022)
Table 16. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lower GI Series as of 2021)
Table 17. Ranking of Global Top Lower GI Series Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Lower GI Series Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lower GI Series Product Solution and Service
Table 21. Date of Enter into Lower GI Series Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lower GI Series Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Lower GI Series Revenue Market Share by Type (2017-2022)
Table 25. Global Lower GI Series Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Lower GI Series Revenue Market Share by Type (2023-2028)
Table 27. Global Lower GI Series Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Lower GI Series Revenue Market Share by Application (2017-2022)
Table 29. Global Lower GI Series Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Lower GI Series Revenue Market Share by Application (2023-2028)
Table 31. North America Lower GI Series Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Lower GI Series Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Lower GI Series Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Lower GI Series Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Lower GI Series Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Lower GI Series Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Lower GI Series Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Lower GI Series Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Lower GI Series Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Lower GI Series Market Size by Country (2023-2028) & (US$ Million)
Table 41. Eisai Company Detail
Table 42. Eisai Business Overview
Table 43. Eisai Lower GI Series Product
Table 44. Eisai Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 45. Eisai Recent Development
Table 46. Cadila Pharmaceuticals Company Detail
Table 47. Cadila Pharmaceuticals Business Overview
Table 48. Cadila Pharmaceuticals Lower GI Series Product
Table 49. Cadila Pharmaceuticals Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 50. Cadila Pharmaceuticals Recent Development
Table 51. Purdue Pharma Company Detail
Table 52. Purdue Pharma Business Overview
Table 53. Purdue Pharma Lower GI Series Product
Table 54. Purdue Pharma Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 55. Purdue Pharma Recent Development
Table 56. Peacehealth Company Detail
Table 57. Peacehealth Business Overview
Table 58. Peacehealth Lower GI Series Product
Table 59. Peacehealth Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 60. Peacehealth Recent Development
Table 61. Novadaq Company Detail
Table 62. Novadaq Business Overview
Table 63. Novadaq Lower GI Series Product
Table 64. Novadaq Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 65. Novadaq Recent Development
Table 66. Astrazeneca Company Detail
Table 67. Astrazeneca Business Overview
Table 68. Astrazeneca Lower GI Series Product
Table 69. Astrazeneca Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 70. Astrazeneca Recent Development
Table 71. Ironwood Pharmaceuticals Company Detail
Table 72. Ironwood Pharmaceuticals Business Overview
Table 73. Ironwood Pharmaceuticals Lower GI Series Product
Table 74. Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2017-2022) & (US$ Million)
Table 75. Ironwood Pharmaceuticals Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lower GI Series Market Share by Type: 2021 VS 2028
Figure 2. Double-Contrast Features
Figure 3. Single-Contrast Features
Figure 4. Global Lower GI Series Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Lower GI Series Report Years Considered
Figure 9. Global Lower GI Series Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Lower GI Series Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Lower GI Series Market Share by Region: 2021 VS 2028
Figure 12. Global Lower GI Series Market Share by Players in 2021
Figure 13. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lower GI Series as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Lower GI Series Revenue in 2021
Figure 15. North America Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Lower GI Series Market Share by Country (2017-2028)
Figure 17. United States Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Lower GI Series Market Share by Country (2017-2028)
Figure 21. Germany Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Lower GI Series Market Share by Region (2017-2028)
Figure 29. China Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Lower GI Series Market Share by Country (2017-2028)
Figure 37. Mexico Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Lower GI Series Market Share by Country (2017-2028)
Figure 41. Turkey Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Lower GI Series Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Eisai Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 44. Cadila Pharmaceuticals Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 45. Purdue Pharma Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 46. Peacehealth Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 47. Novadaq Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 48. Astrazeneca Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 49. Ironwood Pharmaceuticals Revenue Growth Rate in Lower GI Series Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eisai Cadila Pharmaceuticals Purdue Pharma Peacehealth Novadaq Astrazeneca Ironwood Pharmaceuticals